MacroGenics, Inc. MGNX 深 滬
等待開盤 03-26 09:30:00 美东时间
3.17
+0.440
+16.12%
華盛通- 最 高3.21
- 今 開2.78
- 成交量 165.90万股
- 最 低 2.78
- 昨 收 2.73
- 總市值 2.01亿
- 52周最高 3.54
- 市盈率 靜 --
- 換手率 2.61%
- 52周最低 0.9897
- 委 比 61.25%
- 總股本 6355.58万
- 歷史最高 41.00
- 量 比 2.18
- 振 幅 15.75%
- 歷史最低 0.9897
- 每 手 1
- 風險率 0.36%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | VYGR飙升21%，Q4亏损收窄及销售额超预期；Figure大涨超20%
VYGR飙升21%，Q4亏损收窄及销售额超预期；Figure大涨超20%，进军汽车贷款市场获华尔街唱多；Stagwell涨逾17%，引入AppLovin先进的移动广告平台>>
03-11 16:04
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $4
Barclays analyst Etzer Darout maintains Macrogenics (NASDAQ:MGNX) with a Overweight and raises the price target from $3 to $4.
03-10 22:17
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Vir Biotechnology (NASDAQ:VIR) shares moved upwards by 65.0% to $12.26...
02-24 20:05
Why Is MacroGenics Stock Sinking Tuesday?
MacroGenics sees stock decline after FDA places partial clinical hold on Phase 2 LINNET study due to safety concerns.
02-24 19:16
美股牛股 | Medline上市首日大涨超41%，最新市值超322亿美元，为今年最大IPO；Udemy涨超12%
Medline上市首日大涨超41%，最新市值超322亿美元，为今年最大IPO；Udemy涨超12%，与Coursera合并以扩大全球AI教育市场份额>>
2025-12-18 19:07
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
MacroGenics, Inc. announced that its President and CEO, Eric Risser, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on December 4 at 7:55 am ET in Miami, FL. The presentation will be available via webcast under "Events & Presentations" on MacroGenics' Investor Relations website, with an archived replay for 30 days.
2025-11-25 21:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Mersana Therapeutics (NASDAQ:MRSN) stock increased by 208.1% to $27.33...
2025-11-13 20:06
Macrogenics Q3 EPS $0.27 Beats $(0.58) Estimate, Sales $72.839M Beat $14.700M Estimate
Macrogenics (NASDAQ:MGNX) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $(0.58) by 146.31 percent. This is a 70 percent decrease over earnings of $0.90 per share from the
2025-11-13 05:41
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
<p>MacroGenics首席执行官Eric Risser将参加Stifel 2025医疗健康大会炉边谈话。活动时间为2025年11月13日纽约下午4点。网络直播及其存档可在公司投资者关系页面访问。</p>
2025-11-06 21:30
